Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Oncogene|November 7, 2006
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cellsS Sebens Müerköster, V Werbing, B Sipos, et al.
Regulatory Peptides|December 4, 2001
Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosaF Schmitz, M N Göke, J M Otte, et al.
Regulatory Peptides|November 14, 1996
Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptorsD Grandt, M Schimiczek, W Rascher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trialJ M Löhr, S L Haas, W-O Bechstein, et al.
Biochemical and Biophysical Research Communications|August 24, 1992
Novel generation of hormone receptor specificity by amino terminal processing of peptide YYD Grandt, S Teyssen, M Schimiczek, et al.
Peptides|January 1, 1990
Structural characterization of canine PYYV E Eysselein, G A Eberlein, D Grandt, et al.
The American Journal of Physiology|February 11, 1990
Characterization of the major form of cholecystokinin in human intestine: CCK-58V E Eysselein, G A Eberlein, M Schaeffer, et al.
European Journal of Pharmacology|October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptorsD Grandt, F Feth, W Rascher, et al.
Pancreas|March 1, 1995
Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptorsD Grandt, J Siewert, B Sieburg, et al.
Peptides|July 1, 1989
A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)G A Eberlein, V E Eysselein, M Schaeffer, et al.
Pageof 27